246 related articles for article (PubMed ID: 22718320)
21. New developments in the medical treatment of endometriosis.
Bedaiwy MA; Alfaraj S; Yong P; Casper R
Fertil Steril; 2017 Mar; 107(3):555-565. PubMed ID: 28139238
[TBL] [Abstract][Full Text] [Related]
22. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model.
Machado DE; Berardo PT; Landgraf RG; Fernandes PD; Palmero C; Alves LM; Abrao MS; Nasciutti LE
Fertil Steril; 2010 May; 93(8):2674-9. PubMed ID: 20056215
[TBL] [Abstract][Full Text] [Related]
23. Statins as Targeted "Magical Pills" for the Conservative Treatment of Endometriosis: May Potential Adverse Effects on Female Fertility Represent the "Dark Side of the Same Coin"? A Systematic Review of Literature.
Vitagliano A; Noventa M; Quaranta M; Gizzo S
Reprod Sci; 2016 Apr; 23(4):415-28. PubMed ID: 25929256
[TBL] [Abstract][Full Text] [Related]
24. Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis?
Bayoglu Tekin Y; Guven S; Kirbas A; Kalkan Y; Tumkaya L; Guvendag Guven ES
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():1-6. PubMed ID: 25462211
[TBL] [Abstract][Full Text] [Related]
25. Lipoxin A4 inhibits the development of endometriosis in mice: the role of anti-inflammation and anti-angiogenesis.
Xu Z; Zhao F; Lin F; Chen J; Huang Y
Am J Reprod Immunol; 2012 Jun; 67(6):491-7. PubMed ID: 22229383
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic therapies in endometriosis.
Ferrero S; Ragni N; Remorgida V
Br J Pharmacol; 2006 Sep; 149(2):133-5. PubMed ID: 16894342
[TBL] [Abstract][Full Text] [Related]
27. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A
Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695
[TBL] [Abstract][Full Text] [Related]
28. Medical Management of Endometriosis in Patients with Chronic Pelvic Pain.
Bedaiwy MA; Allaire C; Yong P; Alfaraj S
Semin Reprod Med; 2017 Jan; 35(1):38-53. PubMed ID: 28002850
[TBL] [Abstract][Full Text] [Related]
29. Angiogenic properties of endometrial mesenchymal stromal cells in endothelial co-culture: an in vitro model of endometriosis.
Canosa S; Moggio A; Brossa A; Pittatore G; Marchino GL; Leoncini S; Benedetto C; Revelli A; Bussolati B
Mol Hum Reprod; 2017 Mar; 23(3):187-198. PubMed ID: 28158750
[TBL] [Abstract][Full Text] [Related]
30. Future targets in endometriosis treatment: targeting the endometriotic implant.
Nothnick WB; Zhang X
Mini Rev Med Chem; 2009 Mar; 9(3):324-8. PubMed ID: 19275725
[TBL] [Abstract][Full Text] [Related]
31. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of novel fumagillin and ovalicin analogues.
Mazitschek R; Huwe A; Giannis A
Org Biomol Chem; 2005 Jun; 3(11):2150-4. PubMed ID: 15917904
[TBL] [Abstract][Full Text] [Related]
33. Effect of recombinant human endostatin on endometriosis in mice.
Jiang HQ; Li YL; Zou J
Chin Med J (Engl); 2007 Jul; 120(14):1241-6. PubMed ID: 17697575
[TBL] [Abstract][Full Text] [Related]
34. Medical management of endometriosis: a systematic review.
Schroder AK; Diedrich K; Ludwig M
IDrugs; 2004 May; 7(5):451-63. PubMed ID: 15154107
[TBL] [Abstract][Full Text] [Related]
35. β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility.
Abbas MA; Taha MO; Zihlif MA; Disi AM
Eur J Pharmacol; 2013 Feb; 702(1-3):12-9. PubMed ID: 23353590
[TBL] [Abstract][Full Text] [Related]
36. The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions.
Thanatsis N; Filindris T; Siampalis A; Papageorgiou E; Panagodimou E; Adonakis G; Kaponis A
Obstet Gynecol Surv; 2021 May; 76(5):281-291. PubMed ID: 34032860
[TBL] [Abstract][Full Text] [Related]
37. Vasculogenesis: a new piece of the endometriosis puzzle.
Laschke MW; Giebels C; Menger MD
Hum Reprod Update; 2011; 17(5):628-36. PubMed ID: 21586449
[TBL] [Abstract][Full Text] [Related]
38. Antilipidemic ezetimibe induces regression of endometriotic explants in a rat model of endometriosis with its anti-inflammatory and anti-angiogenic effects.
Tapdıgova R; Bayrak G; Yılmaz BC; Aytan H
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):673-680. PubMed ID: 35294604
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulatory therapy for severe influenza.
Darwish I; Mubareka S; Liles WC
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):807-22. PubMed ID: 21810053
[TBL] [Abstract][Full Text] [Related]
40. Plant-derived medicines for treatment of endometriosis: A comprehensive review of molecular mechanisms.
Bina F; Soleymani S; Toliat T; Hajimahmoodi M; Tabarrai M; Abdollahi M; Rahimi R
Pharmacol Res; 2019 Jan; 139():76-90. PubMed ID: 30412733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
